3 results  1 of 1 

1 Factors Associated with Indacaterol Response in Tuberculosis-Destroyed Lung with Airflow Limitation
Tae Hoon Kim, Chin Kook Rhee, Yeon-Mok Oh
Tuberc Respir Dis.2019;82(1):35-41.   Published online 2018 December 19     DOI: http://dx.doi.org/10.4046/trd.2018.0050
      
2 Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea
Ho-Kee Yum, Hak-Ryul Kim, Yoon Soo Chang, Kyeong-Cheol Shin, Song Kim, Yeon-Mok Oh
Tuberc Respir Dis.2017;80(1):52-59.   Published online 2016 December 30     DOI: http://dx.doi.org/10.4046/trd.2017.80.1.52
      
3 Effect of Indacaterol on Cough and Phlegm in Chronic Obstructive Pulmonary Disease Patients: A Meta-Analysis of Five Randomized Controlled Trials
Jinkyeong Park, Jung Su Lee, Chinkook Rhee, Yeon-Mok Oh
J Korean Med Sci.2015;30(10):1453-1458.   Published online 2015 September 12     DOI: http://dx.doi.org/10.3346/jkms.2015.30.10.1453
      

 1 of 1